- Featured Product
- KD/KO Validated
EZH2 Polyklonaler Antikörper
EZH2 Polyklonal Antikörper für FC, IF, IP, WB, ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus, Ratte und mehr (1)
Anwendung
WB, RIP, IP, IF, FC, CoIP, ChIP, ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 21800-1-AP
Synonyme
Galerie der Validierungsdaten
Geprüfte Anwendungen
Erfolgreiche Detektion in WB | DU 145-Zellen, A431-Zellen, C6-Zellen, HEK-293-Zellen, HepG2-Zellen, Jurkat-Zellen, Mausnierengewebe, NIH/3T3-Zellen, Raji-Zellen, Rattennierengewebe |
Erfolgreiche IP | HepG2-Zellen |
Erfolgreiche Detektion in IF | HepG2-Zellen |
Erfolgreiche Detektion in FC | HepG2-Zellen |
Empfohlene Verdünnung
Anwendung | Verdünnung |
---|---|
Western Blot (WB) | WB : 1:5000-1:50000 |
Immunpräzipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunfluoreszenz (IF) | IF : 1:20-1:200 |
Durchflusszytometrie (FC) | FC : 0.20 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Veröffentlichte Anwendungen
KD/KO | See 18 publications below |
WB | See 64 publications below |
IF | See 9 publications below |
IP | See 3 publications below |
CoIP | See 1 publications below |
ChIP | See 6 publications below |
RIP | See 1 publications below |
Produktinformation
21800-1-AP bindet in WB, RIP, IP, IF, FC, CoIP, ChIP, ELISA EZH2 und zeigt Reaktivität mit human, Maus, Ratten
Getestete Reaktivität | human, Maus, Ratte |
In Publikationen genannte Reaktivität | human, Hausschwein, Maus, Ratte |
Wirt / Isotyp | Kaninchen / IgG |
Klonalität | Polyklonal |
Typ | Antikörper |
Immunogen | EZH2 fusion protein Ag16789 |
Vollständiger Name | enhancer of zeste homolog 2 (Drosophila) |
Berechnetes Molekulargewicht | 751 aa, 86 kDa |
Beobachtetes Molekulargewicht | 90-102 kDa |
GenBank-Zugangsnummer | BC010858 |
Gene symbol | EZH2 |
Gene ID (NCBI) | 2146 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Antigen-Affinitätsreinigung |
Lagerungspuffer | PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3. |
Lagerungsbedingungen | Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
EZH2 (enhancer of zeste homologue 2, also known as KMT6) is a member of Polycomb group (PcG) family and encodes a histone methyl transferase that has an essential role in promoting histone H3 lysine 27 trimethylation (H3K27me3) and epigenetic gene silencing. EZH2 is important for cell proliferation and inhibition of cell differentiation, and is implicated in cancer progression. Overexpression of EZH2 is a marker of advanced and metastatic disease in many solid tumors, including prostate and breast cancer. This antibody detected EZH2 protein as a single band with a molecular weight (MW) of 91-100 kDa in multiple cell lines. The phosphorylation may result in the higher molecular weight (calculated MW as 80-86 kDa). (20935635, 21367748)
Protokolle
Produktspezifische Protokolle | |
---|---|
WB protocol for EZH2 antibody 21800-1-AP | Protokoll herunterladen |
IF protocol for EZH2 antibody 21800-1-AP | Protokoll herunterladen |
IP protocol for EZH2 antibody 21800-1-AP | Protokoll herunterladen |
Standard-Protokolle | |
---|---|
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen |
Publikationen
Species | Application | Title |
---|---|---|
Nat Struct Mol Biol lnc-β-Catm elicits EZH2-dependent β-catenin stabilization and sustains liver CSC self-renewal. | ||
Cancer Res HBXIP and LSD1 Scaffolded by lncRNA Hotair Mediate Transcriptional Activation by c-Myc. | ||
Theranostics Histone H3K27 methyltransferase EZH2 regulates apoptotic and inflammatory responses in sepsis-induced AKI
| ||
Nat Commun CDYL suppresses epileptogenesis in mice through repression of axonal Nav1.6 sodium channel expression.
| ||
Clin Cancer Res Single-Cell Analyses Reveal Mechanisms of Cancer Stem Cell Maintenance and Epithelial-Mesenchymal Transition in Recurrent Bladder Cancer.
|
Rezensionen
The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.
FH Nikhil (Verified Customer) (10-16-2019) | very nice
|